Keith Regnante
CHIEF FINANCIAL OFFICER · 2 filings · Latest: Feb 24, 2026
Keros Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
KROS | Keith Regnante | CHIEF FINANCIAL OFFICER | Feb 18, 2026 | Sale | $16.35 | 4,739 | $77.5K | 39,261 |